If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

 

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFusion Antibody Share News (FAB)

Share Price Information for Fusion Antibody (FAB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.40
Bid: 3.30
Ask: 3.50
Change: 0.00 (0.00%)
Spread: 0.20 (6.061%)
Open: 3.40
High: 0.00
Low: 0.00
Prev. Close: 3.40
FAB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Cornerstone FS to beat 2023 expectations

Mon, 04th Dec 2023 10:23

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

----------

AIM - WINNERS

----------

Cornerstone FS PLC, up 26% at 14.48 pence, 12-month range 5.30p-18.50p. The cloud-based payment services provider predicts 2023 adjusted earnings before interest, tax, depreciation and amortisation "materially above current market expectations". "I am pleased to be able to report that we are continuing to experience excellent trading momentum. This reflects the actions that we have taken during the year to enhance our sales team and expand our offer, such as by broadening the range of currencies and countries where we can transact," Chief Executive Officer James Hickman said.

----------

Deltex Medical Group PLC, up 19% at 0.18 pence, 12-month range 0.14p-1.60p. The maker of blood circulation monitoring systems says testing of its TrueVue monitor "has gone to plan" in recent months. "The first in market sale of the new TrueVue monitor was completed at the end of November 2023. In addition, the company has received initial orders for new TrueVue monitors, which it expects to fulfil over the coming months," Deltex adds.

----------

AIM - LOSERS

----------

Fusion Antibodies PLC, down 25% at 4.38p, 12-month range 3.02p-70.00p. The contract research organisation, providing discovery, design and optimisation services for therapeutic antibodies to the healthcare market, reports weaker half-year earnings. Revenue falls to GBP541,000 in the six months to September 30, from GBP1.9 million a year prior. Its pretax loss widens to GBP1.4 million from GBP1.3 million. However, Fusion Antibodies is "confident" that its growth prospects are "increasingly positive", noting that it expects full-year revenue to be "significant weighted towards" the second half of the year ending on March 31.

----------

By Eric Cunha, Alliance News news editor

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
16 Feb 2021 14:24

IN BRIEF: Fusion Antibodies Hires Jones From BrYet To Replace CEO Kerr

IN BRIEF: Fusion Antibodies Hires Jones From BrYet To Replace CEO Kerr

Read more
11 Feb 2021 11:16

Omega Diagnostics Signs Contract To Make Covid Tests; Appoints Chair

Omega Diagnostics Signs Contract To Make Covid Tests; Appoints Chair

Read more
20 Nov 2020 13:25

Fusion Antibodies Half-Year Revenue Rises And Loss Narrows

Fusion Antibodies Half-Year Revenue Rises And Loss Narrows

Read more
13 Nov 2020 16:06

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
27 Oct 2020 15:15

IN BRIEF: Fusion Antibodies Gets Grant From Invest Northern Ireland

IN BRIEF: Fusion Antibodies Gets Grant From Invest Northern Ireland

Read more
24 Sep 2020 16:35

UK DIRECTOR DEALINGS SUMMARY: Supply@Me CEO Buys GBP1 Million Option

UK DIRECTOR DEALINGS SUMMARY: Supply@Me CEO Buys GBP1 Million Option

Read more
18 Sep 2020 21:16

IN BRIEF: Fusion Antibodies Surges On Virus Study Progress

IN BRIEF: Fusion Antibodies Surges On Virus Study Progress

Read more
18 Sep 2020 15:45

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
18 Sep 2020 09:48

Fusion Antibodies soars on Covid-19 test progress

(Sharecast News) - Fusion Antibodies shares soared after the antibody specialist said it had made progress on developing coronavirus antigen tests.

Read more
19 Aug 2020 09:15

Fusion Antibodies Posts Strong Annual Results As Ramps Up Services

Fusion Antibodies Posts Strong Annual Results As Ramps Up Services

Read more
11 Aug 2020 12:36

UK TRADING UPDATE SUMMARY: Codemasters On Up As Finds Right Formula

UK TRADING UPDATE SUMMARY: Codemasters On Up As Finds Right Formula

Read more
6 Jul 2020 16:02

IN BRIEF: Fusion Antibodies Expects Revenue Surge Amid Pandemic

IN BRIEF: Fusion Antibodies Expects Revenue Surge Amid Pandemic

Read more
6 Jul 2020 10:41

Fusion Antibodies FY revenues continue to grow in 2020

(Sharecast News) - Pre-clinical antibodies group Fusion Antibodies said on Monday that revenues had continued to grow over the year ending on 31 March.

Read more
28 Apr 2020 12:28

UK TRADING UPDATE SUMMARY: Zenith Latest To Join Global Drive For PPE

UK TRADING UPDATE SUMMARY: Zenith Latest To Join Global Drive For PPE

Read more
28 Apr 2020 11:19

Fusion Antibodies raises £3m for Covid-19 research

(Sharecast News) - Fusion Antibodies has raised £3m from investors to extend its research to cover potential treatments for Covid-19.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.